SGA has exited its position in Alcon (ALC), selling all shares held by the firm. The decision comes as the company observes a deceleration in demand within the cataract market. Furthermore, SGA has noted a rise in competitive activity impacting the sector.

Key Takeaways

• SGA has sold its entire investment in Alcon (ALC).
• The divestment is attributed to a slowdown in cataract market demand.
• Increased competition in the cataract sector also influenced SGA's decision.

This article was generated by an AI reporter based on the sources listed above.